Skip to main content
CordovaCann Corp. logo

CordovaCann Corp. — Investor Relations & Filings

Ticker · CDVA ISIN · CA21864T1075 CSE Wholesale and retail trade
Open in API
Filings indexed 308 across all filing types
Latest filing 2020-12-21 Regulatory Filings
Country CA Canada
Listing CSE CDVA

About CordovaCann Corp.

https://cordovacann.com/

CordovaCann Corp. is a consumer products company focused on building a diversified cannabis business across multiple jurisdictions. The company specializes in identifying, funding, developing, and managing operations throughout the cannabis value chain, providing services and investment capital to the processing, production, and retail vertical markets. CordovaCann employs a holistic approach to working with partners across North America. Its operational footprint includes owned operations in the United States (Oregon and Washington) and a chain of cannabis retail stores in Canada (Ontario, Manitoba, Alberta, and British Columbia).

Recent filings

Filing Released Lang Actions
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed instructions and form fields related to filing reports of exempt distributions under Canadian securities regulations. It includes references to filing jurisdictions, securities codes, issuer information, and regulatory compliance requirements. The content is a regulatory form used for reporting exempt distributions of securities, not a financial report, earnings release, or management discussion. It is a regulatory filing form used to comply with securities laws, specifically related to exempt distributions. Therefore, the document fits best under the category of Regulatory Filings (RNS), as it is a compliance document and does not represent a financial report or announcement of a report publication.
2020-12-21 English
News release - English.pdf
Regulatory Filings
2020-12-11 English
Interim MD&A - English.pdf
Regulatory Filings
2020-12-04 English
News release - English.pdf
Regulatory Filings Classification · 85% confidence The document is a press release announcing a virtual fireside chat event hosted by Raymond James where VBI Vaccines' leadership will discuss their hepatitis B portfolio. It includes details about the event, company background, and forward-looking statements. There are no financial statements, no detailed financial data, no regulatory filings, or voting results. It is not a transcript of the event but an announcement of the event. The document length is about 5977 characters, which is relatively short and consistent with an announcement. Therefore, this document fits best as an Investor Presentation (IP) type, as it is a detailed presentation for investors focusing on company strategy and product pipeline, albeit in a press release format. However, since it is an announcement of a presentation event rather than the presentation itself, and it is not a report or transcript, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other categories better.
2020-12-02 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Unaudited Condensed Interim Consolidated Financial Statements' for the three months ended September 30, 2020 and 2019. It contains detailed financial statements including statements of financial position, operations, changes in equity, cash flows, and notes. The presence of actual financial data and the interim period (quarterly) indicates this is a comprehensive interim financial report. The document length is substantial (15,000 characters), and it is not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2021
2020-12-01 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS' and is a certification by the CEO regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2020. The content is primarily an officer certification letter confirming the accuracy and completeness of the interim filings, without containing actual financial data or substantive financial analysis. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3037 characters, which is relatively short and consistent with a certification letter rather than a full interim report.
2020-12-01 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.